Gamma interferon (IFN--y) plays an important role as a host defense in rickettsial infection. Swiss Webster mice, which are resistant to Rickettsia conorii (Malish 7 strain) infection, were treated with a monoclonal antibody against mouse IFN--y. When the antibody-treated mice were inoculated with 12 50% tissue culture infective doses of R. conorii, the mortality was 47% and the morbidity was 100%. None of the control mice, which received the same dose of R. conorii, died or became ill. The enumeration of rickettsiae in organs by direct immunofluorescence in paraffin sections demonstrated higher quantities of rickettsiae in the spleen and liver of IFN-'y-depleted mice as compared with those of the infected controls. The kinetic analysis of IFN-y levels in sera showed depletion in the treated mice. These results indicate that IFN-,y plays an important role as a host defense in the early stage of rickettsial infection. Survival of some mice despite continued treatment with antibody to IFN-'y suggests that other immune mechanisms may also be important.
The mechanisms of host defense against rickettsial infection have been studied extensively. It has been demonstrated that the development of cell-mediated immunity is a very important antirickettsial response (8, 9, 11, 16, 23) . Lymphokines from the supernatant of cultured lymphocytes stimulated with rickettsial antigens or concanavalin A activated macrophages and inhibited the multiplication of rickettsiae in macrophages, macrophagelike cells, fibroblasts, and endothelial cells (12, 13, 18) .
The activity of lymphokines on cells to induce antirickettsial effects shares many characteristics with gamma interferon (IFN-,y) (20, 21, 25) . Expression of activity requires protein synthesis by host cells, and the antirickettsial activity is destroyed by exposure to pH 2, heat (80°C), and trypsin. Either IFN-like lymphokines or cloned mouse IFN--y can inhibit multiplication of rickettsiae in infected cells (14, 15, 19) and induce cytolysis of rickettsia-infected phagocytic cells (21, 25) . This suggests that the interaction between the infected cell and the effector mechanisms is a part of antirickettsial immunity. Elimination of lymphokine-mediated antirickettsial activity by monoclonal antibody specific for murine IFN-y in in vitro assays suggested that IFN-,y is an important factor in the antirickettsial activity of lymphokines (5) .
This study presents evidence that IFN--y plays a key role in host resistance to rickettsial infection in vivo. Swiss Webster mice, which are resistant to a high challenge dose of Rickettsia conorii, died from overwhelming rickettsial infection when depleted of IFN--y by a monoclonal antibody and infected with a low dose of R. conorii.
MATERIALS AND METHODS
Mice. Male Swiss Webster mice, 6 to 8 weeks of age, were purchased from Jackson Laboratory, Bar Harbor, Maine.
Rat anti-murine IFN--y monoclonal antibody. The rat hybridoma R4-6A2 producing monoclonal anti-murine IFN--y antibody was prepared, and the antibody was characterized * Corresponding author.
by Spitalny and Havell (17) . Antibody used in the present study was obtained by growing hybridoma cells in BALB/c athymic mice (Charles River Breeding Laboratories, Inc., Wilmington, Mass.) and collecting the ascitic fluid from the mice. The ascitic fluid was stored at -70°C and filter sterilized before use. The anti-IFN-y titer of the ascitic fluid was 4.2 x 105 neutralizing units per 0.1 ml, as determined by neutralization of antiviral activity of a standardized lymphokine preparation as previously described (17).
Mouse monoclonal antibody against Vero cell cytoskeleton.
A mouse monoclonal antibody against a Vero cell cytoskeletal antigen was prepared in this laboratory as described previously (2) . The titer by direct immunofluorescence assay was 1:10,240.
Rickettsia. R. conorii (Malish 7 strain) was obtained from the American Type Culture Collection, Rockville, Md., and was plaque purified and shown to be mycoplasma-free. The rickettsial inoculum was cultivated in yolk sacs of 5-day-old specific-pathogen-free embryonated chicken eggs (SPAFAS, Inc., Norwich, Conn.); 10% infectious yolk sac suspension contained 106.25 50% tissue culture infective doses (TCID50) per ml for primary chicken embryo cells. Rickettsiae were stored at -70°C before dilution in sucrose phosphate glutamate buffer, pH 7.0 (0.218 M sucrose, 0.0038 M KH2PO4, 0.0086 M Na2HPO4, 0.0049 M glutamate) for inoculation of 12 TCID50 per mouse.
Experimental design. Mice were divided into four groups. All the mice that received either monoclonal antibody were treated on days 0, 1, 3, 5, and 7 after infection. Rat Enumeration of rickettsiae in organs. Rickettsiae were enumerated in formaldehyde-fixed, paraffin-embedded tissue by an immunofluorescence technique (22) . Sections were affixed to slides with Weld Wood white glue (Roberts Consolidated Industries). The deparaffinized, trypsin-digested slides were reacted with a specific fluorescein isothiocyanate-conjugated globulin fraction of rabbit antiserum reactive with spotted fever group rickettsiae obtained from the Centers for Disease Control, Atlanta, Ga., as described previously (22) . The slides were examined by UV microscopy with barrier and exciter filters for fluorescein isothiocyanate. Rickettsiae in 10 fields were counted at x1,000 magnification, and the average number of rickettsiae per field was cafculated.
Assay for cytopathic effect. The dilution at which 50% protection was observed is the endpoint. Assay of serum anti-IFN-y antibody. The presence and quantity of antibody to IFN--y in mouse serum were assayed by the neutralization of antiviral activity in a lymphokine preparation containing IFN-y, as described previously (17). A lymphokine preparation containing 10 U of IFN--y per ml and sera collected from anti-IFN-y-treated mice were added to monolayers of L-929 cells in 96-well plates. Then, the monolayers were infected with vesicular stomatitis virus. The dilution of serum that neutralized the antiviral activity of 10 U of IFN is the titer of antibody to IFN--y.
RESULTS
All the mice in group 1, which received antibody to murine IFN-y and R. conorii, were ill on day 5 after infection. They were thin and inactive with ruffled fur. These animals began to die from rickettsial infection on day 7 postinfection. The morbidity was 100%, and mortality was 47%. No mice from the three control groups became ill or died. The IFN levels are presented in Table 1 . The antiviral activity of the sera of mice treated with antibody to murine IFN-y was lower than that of the infected control mice. IFN-,y was detected in a few samples and at low titer in the anti-IFN--y-treated mice. In contrast, IFN--y was first noted in the sera of all untreated, infected controls on day 6 after infection and persisted for 1 week. IFN-ca/I as defined by pH 2 stability was found in the sera of mice treated with anti-murine IFN-,y during the early stage of infection, and beyond 6 days after infection, it was no longer detectable. No IFN-oa/3 was detected in the sera of untreated mice. Antibody to IFN--y in the sera of treated mice was detectable during the first 8 days of infection, the first 7 days of which animals received antibody to IFN--y.
The average anti-IFN-y titer in sera of treated mice for this period was 1:16. After day 8, the titer of residual circulating anti-IFN--y antibody decreased and was undetectable by days 12 to 14.
In all experiments performed, some animals in the group treated with anti-murine IFN-y and infected with R. conorii survived the infection. Recovery from the rickettsial infection was evident on day 9 after infection, and even if anti-murine IFN-y was given continuously after day 9 of infection, animals alive on day 9 survived the infection (data not shown).
The enumeration of rickettsiae in organs by direct immunofluorescence on paraffin-embedded sections demonstrated higher quantities of rickettsiae in the spleens and livers of mice which received the monoclonal antibody to murine IFN-y and R. conorii than in those of the control groups (Table 2) . From day 5 after infection, IFN-depleted mice had numerous rickettsiae in the spleen and liver; only a few rickettsiae could be found in the organs of the control mice. On day 10 after infection, the quantity of rickettsiae in the organs of the treated mice decreased dramatically and approached that of control mice. Among the organs examined, the spleen was infected the most severely. (19, 21, 25) . The antirickettsial activity requires protein synthesis by host cells, and the activity can be destroyed by trypsin, heating to 80°C, and exposure to low pH. The cytolytic action is specific for rickettsia-infected cells and does not act on uninfected cells (25) . This situation suggests the possibility that the surface of the infected cells had been altered in some way by the intracellular rickettsial infection (25) . Either rabbit antisera to purified murine IFN-y or rat monoclonal antibody to murine IFN-y neutralizes the antirickettsial activity of lymphokine preparations and cloned mouse IFNy (5, 20) (6, 7, 24) . In these studies, it was reported that the protective IFN was of the cta/ type. In this study, we found IFN-a/, in the treated mouse blood at an early stage of infection, but it was not protective as compared with that of the control mice. Turco and Winkler reported that a preparation of virus-induced IFNs (a/p) had no detectable antirickettsial activity (20) . It is not clear why the finding of pH 2-stable IFN in the sera of anti-murine IFN--y-treated mice was relatively inconsistent; however, the levels were always low and near the level of detection in this assay. This and the fact that the mice used in this study were outbred perhaps are the reasons that pH 2-stable IFN was not always detectable in the sera of treated, infected animals.
The quantities of rickettsiae in organs of experimental and control groups are quite different. The lethal infection of IFN--y-depleted mice is systemic and results from specific rickettsial infection. The reduction in levels of IFN-y in the blood of treated mice suggests that the monoclonal antibody entered the circulation and neutralized IFN-y.
The recovery of anti-murine IFN--y-treated mice from infection is not associated with an increase in the level of IFN--y in the blood of the animals. The IFN--y levels remained undetectable in treated mice even after treatment with anti-murine IFN--y was discontinued. Moreover, mice which received antibody continually even after day 9 still survived. That there are other components of the immmune system that are activated during the infection is suggested since recovery of mice did not result from an increase in IFN--y levels. Palmer et al. reported that the peak of IFN--y production occurred earlier than did the peak of protection from animal death (14) . This also suggests that immunity to rickettsiae is due not only to IFN-y but also to some other immune mechanism(s) or nonspecific host defense mechanism, as described for R. tsutsugamushi (4) .
